| Literature DB >> 29498095 |
Zizhao Wu1, Xianjian Qiu1, Bo Gao1, Chengjie Lian2, Yan Peng1, Anjing Liang1, Caixia Xu3, Wenjie Gao2,4, Liangming Zhang5, Peiqiang Su2,6, Limin Rong5, Dongsheng Huang1.
Abstract
Bone marrow-derived mesenchymal stem cells (BMSCs), with inherent chondrogenic differentiation potential appear to be ideally suited for therapeutic use in cartilage regeneration. Accumulating evidence has demonstrated that melatonin can promote chondrogenic differentiation in human BMSCs. However, little is known about the mechanism. MicroRNAs (miRNAs) have been shown to regulate the differentiation of BMSCs, but their roles in melatonin-promoted chondrogenic differentiation have not been characterized. Here, we demonstrate that melatonin promoted chondrogenic differentiation of human BMSCs via upregulation of miR-526b-3p and miR-590-5p. Mechanistically, the elevated miR-526b-3p and miR-590-5p enhanced SMAD1 phosphorylation by targeting SMAD7. Additionally, administration of miR-526b-3p mimics or miR-590-5p mimics successfully promoted the chondrogenic differentiation of human BMSCs. Collectively, our study suggests that modification of BMSCs using melatonin or miRNA transduction could be an effective therapy for cartilage damage and degeneration.Entities:
Keywords: SMAD7; chondrogenesis; human mesenchymal stem cells; melatonin; miR-526b-3p; miR-590-5p
Mesh:
Substances:
Year: 2018 PMID: 29498095 DOI: 10.1111/jpi.12483
Source DB: PubMed Journal: J Pineal Res ISSN: 0742-3098 Impact factor: 13.007